Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Recruiting

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

NCT05239624

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Baptist Alliance MCI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Recruiting

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

NCT07390617

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

NCT05562830

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045) Orange, California, United States
  • University of California San Francisco ( Site 1044) San Francisco, California, United States
  • Anschutz Cancer Pavilion ( Site 1017) Aurora, Colorado, United States
  • University of Chicago Medical Center ( Site 1037) Chicago, Illinois, United States
View all 28 locations
View Trial Details
Recruiting

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

NCT07334119

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +47 more
Locations
  • The Kinghorn Cancer Centre Darlinghurst, New South Wales, Australia
  • Scientia Clinical Research Ltd Randwick, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +33 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • The Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde Glasgow, United Kingdom
View Trial Details

Related conditions